physiologically based pharmacokinetic modeling
Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability
... silico physiologically based pharmacokinetic modeling ...FeSSIF. Pharmacokinetic clinical trial simulations were con- ducted using Simcyp (Version 14), incorporating P app and ...
16
Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content
... a physiologically based pharmacokinetic model was utilized to interpret the effects of nanoparticle properties on previously published biodistribution ...A physiologically based ...
12
<p>Ethosome-Derived Invasomes as a Potential Transdermal Delivery System for Vardenafil Hydrochloride: Development, Optimization and Application of Physiologically Based Pharmacokinetic Modeling in Adults and Geriatrics</p>
... of physiologically based pharmacoki- netic (PBPK) modeling had attracted great attention in the last years as a novel approach to estimate the drug pharma- cokinetics following administration in one ...
15
Physiologically based pharmacokinetic modeling of benzene metabolism in mice through extrapolation from in vitro to in vivo
... ÞàDá â:ãåä æèçéê ÛëÈÎ>Å&ÆÖ#ìØFÈ/ÉÐÌ&í&î çïéïê îÐ?Ö+ÉÐÆÎÐÑ#Î3Ò>Ö#ÈðÎÍ$ñ5ÖdÉÈÐÎØRñ5ÖdÉÐ$ÉÈòÐÖdñ5È/ó9Ç5ÊÐÆòÈoÈôTðÐ$ÉÅ&ÍÆ-Å&Ö ðÖ#ÈÎoÉÍWÎÈÖ#ÇÑ#Å&Ë1È Ë1ÈÆÕÈÆÈ&l[r] ...
27
In vivo biodistribution and physiologically based pharmacokinetic modeling of inhaled fresh and aged cerium oxide nanoparticles in rats
... is based on our previous version for intraven- ously injected nanoparticles already published [23, 35], ex- tended for inhalation exposure by including deposition in the respiratory system and transfer to the GI ...
20
<p>The Effect of Liver and Kidney Disease on the Pharmacokinetics of Clozapine and Sildenafil: A Physiologically Based Pharmacokinetic Modeling</p>
... enzymes but speci fi cally CYPs 1A2, 2D6 2C19, and 3A4; enzyme expression is reduced as disease severity increases. 43 Liver failure can alter a few elements of medication PK, including absorption, distribution and ...
11
Physiologically based pharmacokinetic modeling of nanoceria systemic distribution in rats suggests dose- and route-dependent biokinetics
... Our PBPK model includes saturable uptake of nanoceria in PCs as a major feature. At sufficiently high doses, tissue levels will be less than proportional to dose as the PCs approach saturation. Moreover, PCs are unevenly ...
16
Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination
... PBPK modeling is deeply rooted in the independence of the model building on the output data representing the process to be ...is based on the integration within a whole entity of drug specific character- ...
13
Physiologically based pharmacokinetic modeling of zinc oxide nanoparticles and zinc nitrate in mice
... Abstract: Zinc oxide nanoparticles (ZnO NPs) have been widely used in consumer products, therapeutic agents, and drug delivery systems. However, the fate and behavior of ZnO NPs in living organisms are not well ...
16
Application of physiologically based pharmacokinetic modeling in predicting drug–drug interactions for sarpogrelate hydrochloride in humans
... Here, we developed a PBPK model that linked sar- pogrelate hydrochloride to its active metabolite M-1 for simulating the DDIs of sarpogrelate with the clinically relevant CYP2D6 substrates, metoprolol, desipramine, dex- ...
14
Prediction of human CNS pharmacokinetics using a physiologically-based pharmacokinetic modeling approach
... scaled based on di ff erences in expression of the pertinent transporters in both ...available pharmacokinetic (PK) data in human brain extracellular fl uid and/or cerebrospinal fl uid, obtained under phy- ...
13
Compartmentalizing the Sunlight Vitamin: Physiologically Based Pharmacokinetic Modeling and Vitamin D.
... A pharmacokinetic model is a quantitative, rather than qualitative description of chemical behavior in biological systems over a period of ...tissues. Physiologically- based pharmacokinetic ...
140
Physiologically based pharmacokinetic (PBPK) modeling of benzene in humans: a Bayesian approach
... Physiologically based pharmacokinetic (PBPK) models are standard tools that are now often used in risk assessment to better extrapolate from experimental animals to humans and from high to low ...
33
A Comparison of Physiologically-Based Pharmacokinetic (PBPK) Models of Methyl-Tertiary Butyl Ether (MTBE).
... mathematical modeling perspective, the analysis of a descriptive or predictive model that fits the data collected from a study may provide some information that could possibly drive the design of future kinetic ...
135
PKQuest Java: free, interactive physiologically based pharmacokinetic software package and tutorial
... Two "high fat soluble" drug classes are discussed in the tutorial as examples of drugs whose tissue/partition coef- ficient can be predicted from in vitro measurements of fat/ water partition. The first are the ...
6
Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles
... Abstract: To assess the potential toxicity of nanoparticles (NPs), information concerning their uptake and disposition (biokinetics) is essential. Experience with industrial chemicals and pharmaceutical drugs reveals ...
16
Applications of Physiologically Based Pharmacokinetic Models in Veterinary Medicine.
... probabilistic modeling technique that uses distributions rather than single points to define ...PBPK modeling and have been applied to human health risk assessment (Cox, 1996; Jonsson et ...
166
Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112
... in pharmacokinetic modeling due to their differences in disposition processes, such as tissue ...constructed based on the nonparticulate PBPK model (Figure ...
15
Comparative Pharmacokinetic Approaches to Estimating the Pharmacokinetics of Water Medications in Swine
... PBPK modeling uses physiologically important parameters to develop a model that predicts known data (Kawai et ...compartmental modeling; however, rather than allowing the drug profile to determine ...
138
PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL FOR PLANT BASED ANTI OXIDANT DRUGS
... of physiologically-based pharmacokinetic (PBPK) study is necessary for the validation of ...PBPK modeling and simulation is a tool that can help predict the pharmacokinetics of drugs in humans ...
7